B2M overexpression correlates with malignancy and immune signatures in human gliomas

Because of the limited treatment strategy of gliomas, the key of diagnosis and treatment is finding new molecular biomarkers. Here, we explored the potential of β2-microglobulin (B2M) to serve as a hopeful candidate for immunotherapy or diagnostic biomarker in gliomas. The genomic profiles, clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hao, Cui, Biqi, Zhou, Yulai, Wang, Xinxing, Wu, Wantao, Wang, Zeyu, Dai, Ziyu, Cheng, Quan, Yang, Kui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930032/
https://www.ncbi.nlm.nih.gov/pubmed/33658560
http://dx.doi.org/10.1038/s41598-021-84465-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930032/
https://www.ncbi.nlm.nih.gov/pubmed/33658560
http://dx.doi.org/10.1038/s41598-021-84465-6

Ejemplares similares